Corcept Therapeutics
Price & Volume
Stats
See more52W Range | $28.66-$117.33 |
Market Cap | $3.6B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $741.1M |
Revenue Growth (YoY) | 13.7% |
Gross Profit (12 Mos) | $727.7M |
Diluted EPS | $0.87 |
News
See moreYahoo Finance • 6 days ago
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Yahoo Finance • 11 days ago
High Insider Ownership Fuels Growth Stocks In February 2026
Yahoo Finance • 12 days ago
3 Growth Companies With High Insider Ownership Expecting Up To 81% Earnings Growth
Yahoo Finance • 13 days ago
3 High Growth Companies With Strong Insider Ownership
About
CEO | Dr. Joseph K. Belanoff M.D. |
CFO | Mr. Atabak Mokari |
Address | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 500 |
